BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23871438)

  • 1. To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion.
    Patterson NJ; Werling D
    Vet Immunol Immunopathol; 2013 Sep; 155(3):147-54. PubMed ID: 23871438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial TIR-containing proteins and host innate immune system evasion.
    Rana RR; Zhang M; Spear AM; Atkins HS; Byrne B
    Med Microbiol Immunol; 2013 Feb; 202(1):1-10. PubMed ID: 22772799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
    Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
    Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella Coiled-Coil- and TIR-Containing TcpS Evades the Innate Immune System and Subdues Inflammation.
    Xiong D; Song L; Geng S; Jiao Y; Zhou X; Song H; Kang X; Zhou Y; Xu X; Sun J; Pan Z; Jiao X
    Cell Rep; 2019 Jul; 28(3):804-818.e7. PubMed ID: 31315056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
    Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
    J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
    Doyle SL; O'Neill LA
    Biochem Pharmacol; 2006 Oct; 72(9):1102-13. PubMed ID: 16930560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways.
    Narayanan KB; Park HH
    Apoptosis; 2015 Feb; 20(2):196-209. PubMed ID: 25563856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor downstream signaling.
    Kawai T; Akira S
    Arthritis Res Ther; 2005; 7(1):12-9. PubMed ID: 15642149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of Toll/interleukin-1 receptor/resistance protein (TIR) domains.
    Ve T; Williams SJ; Kobe B
    Apoptosis; 2015 Feb; 20(2):250-61. PubMed ID: 25451009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [TIR domain--containing adaptors regulate TLR-mediated signaling pathways].
    Yamamoto M; Akira S
    Nihon Rinsho; 2004 Dec; 62(12):2197-203. PubMed ID: 15597785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique features of chicken Toll-like receptors.
    Keestra AM; de Zoete MR; Bouwman LI; Vaezirad MM; van Putten JP
    Dev Comp Immunol; 2013 Nov; 41(3):316-23. PubMed ID: 23628643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TLR signalling adaptor TRIF/TICAM-1 has an N-terminal helical domain with structural similarity to IFIT proteins.
    Ullah MO; Ve T; Mangan M; Alaidarous M; Sweet MJ; Mansell A; Kobe B
    Acta Crystallogr D Biol Crystallogr; 2013 Dec; 69(Pt 12):2420-30. PubMed ID: 24311583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
    Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
    Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of Toll/Interleukin-1 Receptor (TIR) domain sequences from rhesus macaque Toll-like receptors (TLRs) 1-10 reveals high homology to human TLR/TIR sequences.
    Sanghavi SK; Shankarappa R; Reinhart TA
    Immunogenetics; 2004 Dec; 56(9):667-74. PubMed ID: 15578265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral interference with innate immunity by preventing NF-κB activity.
    Le Negrate G
    Cell Microbiol; 2012 Feb; 14(2):168-81. PubMed ID: 22050732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.